MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51 | +41.7% | 1,172 | +16.7% | 0.00% | – |
| Q2 2023 | $36 | -5.3% | 1,004 | -2.3% | 0.00% | – |
| Q1 2023 | $38 | -22.4% | 1,028 | -4.4% | 0.00% | – |
| Q4 2022 | $49 | -99.9% | 1,075 | -0.5% | 0.00% | -100.0% |
| Q3 2022 | $75,000 | +2.7% | 1,080 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $73,000 | +812.5% | 1,080 | +1025.0% | 0.00% | – |
| Q1 2022 | $8,000 | +166.7% | 96 | +380.0% | 0.00% | – |
| Q4 2021 | $3,000 | – | 20 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $688,784,000 | 67.42% |
| Avoro Capital Advisors LLC | 4,535,000 | $996,067,000 | 17.15% |
| Darwin Global Management, Ltd. | 260,876 | $57,299,000 | 15.99% |
| Boxer Capital, LLC | 1,765,560 | $387,788,000 | 12.46% |
| Perceptive Advisors | 3,693,516 | $811,244,000 | 8.71% |
| Consonance Capital Management LP | 330,000 | $72,481,000 | 6.77% |
| EcoR1 Capital, LLC | 464,298 | $101,978,000 | 5.48% |
| Fairmount Funds Management LLC | 60,500 | $13,288,000 | 4.75% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,400 | $14,804,000 | 4.04% |
| RTW INVESTMENTS, LP | 1,054,364 | $231,581,000 | 3.88% |